NICOLE FALDMO: Open Payments
NPI 1679809008 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 56 payments from 17 companies in 2025. Trend: 2023 $1,358 · 2024 $1,509 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $417 |
| UCB, Inc. | 8 | $155 |
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| Arcutis Biotherapeutics, Inc. | 5 | $104 |
| Amgen Inc. | 4 | $81 |
| LEO Pharma Inc. | 3 | $63 |
| Janssen Biotech, Inc. | 3 | $54 |
| ABBVIE INC. | 3 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $52 |
| Incyte Corporation | 2 | $44 |
Products named: DUPIXENT, Bimzelx, COSENTYX, Zoryve, OTEZLA, LIBTAYO, ADBRY, TREMFYA.
Industry payments across AZ — which companies pay providers there.
